Award

Skiniotis has ‘outstanding talent,’ ‘technical prowess’

He won the ASBMB's Earl and Thressa Stadtman Scholar Award
Ulli Hain
By Ulli Hain
March 1, 2016

Georgios Skiniotis, associate professor of biological chemistry at the University of Michigan Life Sciences Institute and the University of Michigan Medical School, is the co-winner of the 2016 American Society for Biochemistry and Molecular Biology Earl and Thressa Stadtman Scholar Award for his innovative use of electron microscopy. The award, given every other year, honors outstanding researchers with fewer than 10 years of post-postdoctoral experience.

Skiniotis-Georgios-235x293.jpg
“It’s an honor for our lab to receive an award named after such pioneers as Earl and Thressa Stadtman. Cryo-EM is a fast evolving technology poised to shed light on the mechanisms underlying complex cellular processes; in its application we strive to embody and transmit the tradition of excellent basic science and passion for discovery that is the Stadtmans’ legacy.” — Georgios Skiniotis

To initiate intracellular signaling, G-protein–coupled receptors, or GPCRs, on the surface of our cells transmit diverse information, such as hormones, neurotransmitters and light from our environment. Skiniotis pioneered the use of single-particle electron microscopy, or EM, to study GPCRs in complex with their cognate G proteins. These structures were groundbreaking in terms of both the small size of the analyzed proteins and the surprising amount of movement within the receptor-bound G protein.

In her letter nominating Skiniotis for the award, colleague Janet L. Smith at the University of Michigan said Skiniotis’ “rare combination of outstanding talent in biochemistry and technical prowess with electron microscopy has allowed him to push the boundaries of EM analysis and obtain structural information from molecules and assemblies formerly considered too small for single particle reconstruction.” She added that he has also “fearlessly tackled problems of great biological and chemical importance.”

Skiniotis’ work has important implications for human disease, because understanding the structural mechanism behind GPCRs allows for the development of novel therapies that target these receptors.

During his dissertation work at the European Molecular Biology Laboratory, Skiniotis developed a novel technique for labeling proteins for cryo-EM analysis. He used this technique to study the movement and processivity of the motor protein kinesin. He demonstrated that tubulin is not just a track for kinesin but rather actively modulates kinesin movement.

Most recently, Skiniotis applied his EM expertise to better understand polyketide synthesis by the multidomain polyketide synthases, or PKSs. Polyketides are naturally produced and structurally complex compounds. Many polyketides have antimicrobial, antifungal or immunosuppressant activity, and nearly a third of pharmaceuticals are based on or inspired by polyketides. By understanding the mechanism behind these polyketide factories, it may be possible to bioengineer PKSs to create novel antibiotics.

Skiniotis recently published a stunning series of structures of a PKS module in the journal Nature. In his letter supporting Skiniotis' nomination, Stephen Harrison at Harvard Medical School, who interacted with Skiniotis when the latter was a postdoctoral fellow at the school, described the series as “triumphs of structural biology.” The structures not only represent the complete enzymatic cycle of a full PKS module for the first time but also detail an unexpected architecture. Unlike the related mammalian fatty acid synthase, the bacterial PKS module forms an arch-shaped dimer that creates a single chamber for the acyl carrier protein to deliver its substrate to the different active sites within the module.

Skiniotis adds the Earl and Thressa Stadtman Scholar Award to an already impressive résumé. He was named a Pew Scholar in Biomedical Sciences in 2011 and received the Presidential Early Career Award for Scientists and Engineers in 2012.

Watch his award lecture, “Molecular choreography of an antibiotic assembly line,” below.

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Ulli Hain
Ulli Hain

Ulli Hain received her Ph.D. from the Johns Hopkins University. She is a science writer at Palladian Partners, Inc.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Piehl promoted to associate professor
Member News

Piehl promoted to associate professor

May 4, 2026

He plans to develop a first-year chemistry lab program designed to help students build essential laboratory skills and connect core chemical concepts with real-world challenges.

In memoriam: Susan A. Henry
In Memoriam

In memoriam: Susan A. Henry

May 4, 2026

She was a pioneer in the study of yeast genetics and lipid metabolism and was an editorial board member of the Journal of Biological Chemistry.

ASBMB recognizes Chapman as 2026 outstanding student chapter
Student Chapters

ASBMB recognizes Chapman as 2026 outstanding student chapter

May 1, 2026

The group, led by Cedric Owens, is being honored for its commitment to scientific engagement, mentorship and community building, creating meaningful opportunities for students in biochemistry and molecular biology.

Park wins Parkinson’s award
Member News

Park wins Parkinson’s award

April 27, 2026

He is one of three individuals who will receive $90,000 to fund their research.

In memoriam: George C. Hill
In Memoriam

In memoriam: George C. Hill

April 27, 2026

He conducted groundbreaking research on African sleeping sickness, supported countless underrepresented students in medical education and was an ASBMB member for 43 years.

Luger wins Vilcek Prize
Member News

Luger wins Vilcek Prize

April 20, 2026

The $100,000 award honors an immigrant scientist in the U.S. whose research has had a significant impact and who demonstrates exceptional leadership in advancing biomedical science.